Clinical Trial Update: A Study to Learn About the Effects of Felzartamab Infusions in Adults With Kidney Transplants Who Have Late Isolated Microvascular Inflammation [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial by Biogen is evaluating felzartamab infusions in adults with kidney transplants who have late isolated microvascular inflammation and i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant Rejection

Drugs mentioned

• Felzartamab (felzartamab)

Snippet

Sponsor: Biogen | Conditions: Microvascular Inflammation | Phase 2 | Status: RECRUITING